Subscribe to Search results

David Gury at Alpha sent out a series of urgent communications on AIDS on their new donor selection policies which were due to be be given to donors, deferred donors and donor centre personnel.

Published on:

Dr Lane focused on the view that BPL should be rebuilt. A large investment was required.

Published on:

The Expert Group on the Treatment of Haemophilia had set a goal of 250,000 donations to be used for Factor 8 concentrate (March 1973); this had been increased to 275,000 by regional transfusion directors following the Joint Steering Committee (June and July 1973).

Published on:

Dr Bowley wrote a letter to colleagues seeking to make a case for using better quality cryoprecipitate instead of imported factor concentrates.

Published on:

Dr Biggs wrote to Dr Waiter discussing seeking an increase in the supplies of commercially produced concentrates.

Published on:

By 1976, 46% of donations in Scotland were issued as red cell concentrates. By 1982, 60% of donations were being processed into red cell concentrates with 200ml of plasma removed.

Published on:

A Working Party on Human AHG meeting debated where the preparation of AHG should take place.

Published on:

Ministers continued to stress the need for collaboration between Scotland and England in manufacturing blood products.

Published on:

A NBTS meeting was held when it became apparent that any further plasma provided to BPL for fractionation would have to be dealt with in "unsatisfactory accommodation".

Published on:

R Smart published a report titled "Blood Products Laboratory: Redevelopment".

Published on:

At a meeting of the Scientific and Technical Committee for the Central Blood Laboratories, members did not support commercial development, and recommended that no time should be lost in planning for a completely new NHS plant.

Published on:

Ministers decided to defer the eventual decision on whether to build a new laboratory within the NHS until other possibilities had been investigated.

Published on:

Dr Lane was authorised to proceed with the stop-gap project. The DHSS anticipated that the sum of £750,000 would be available for the capital development of BPL in 1980/1981.

Published on:

It was not until this time that Dr Lane was given formal authority to proceed to tender with MARP01, the name given to the stop-gap proposal.

Published on:

Dr Gunson tabled a paper concluding that the number of plasmapheresis facilities should be increased. The Advisory Committee of the NBTS agreed to set up a Working Party and liaise with Scotland.

Published on:

The Working Party to Advise on Plasma Supplies for Self-Sufficiency in Blood Products published a preliminary report estimating costs of plasmapheresis compared favourably with the estimated cost of obtaining the same weight of whole blood.

Published on:

A Policy Steering Group for the Redevelopment of BPL meeting was held.

Published on:

Angus MacPherson wrote a letter to John Harley discussing the results of the shift working trial and outlining that the necessary building works could be completed in approximately two and a half years.

Published on:

A meeting of regional transfusion directors was held at BPL to receive information concerning the future requirements for increased supply of plasma for fractionation.

Published on:

A report was published titled "Value of SAG-M Systems in the Provision of Plasma Products".

Published on: